Your browser is no longer supported. Please, upgrade your browser.
Settings
SGNL Signal Genetics, Inc. daily Stock Chart
SGNL [NASD]
Signal Genetics, Inc.
Index- P/E- EPS (ttm)-14.10 Insider Own5.10% Shs Outstand0.70M Perf Week4.28%
Market Cap6.99M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float0.50M Perf Month66.22%
Income-10.10M PEG- EPS next Q- Inst Own6.50% Short Float0.97% Perf Quarter36.48%
Sales3.20M P/S2.19 EPS this Y60.00% Inst Trans- Short Ratio0.04 Perf Half Y26.62%
Book/sh6.52 P/B1.53 EPS next Y- ROA-100.10% Target Price33.75 Perf Year15.83%
Cash/sh7.71 P/C1.29 EPS next 5Y- ROE-135.00% 52W Range1.80 - 17.74 Perf YTD99.40%
Dividend- P/FCF- EPS past 5Y- ROI-97.30% 52W High-43.69% Beta-
Dividend %- Quick Ratio2.30 Sales past 5Y- Gross Margin28.60% 52W Low455.00% ATR1.77
Employees32 Current Ratio2.30 Sales Q/Q80.00% Oper. Margin- RSI (14)54.84 Volatility14.40% 26.98%
OptionableNo Debt/Eq0.23 EPS Q/Q56.10% Profit Margin- Rel Volume0.16 Prev Close9.37
ShortableYes LT Debt/Eq0.00 EarningsNov 14 Payout- Avg Volume127.49K Price9.99
Recom2.00 SMA2038.26% SMA5032.77% SMA20031.66% Volume20,975 Change6.62%
Jan-08-16Initiated Rodman & Renshaw Buy $4
Jul-01-15Reiterated Chardan Capital Markets Buy $2.50 → $2.75
Jun-23-15Initiated Chardan Capital Markets Buy $2.50
Sep-09-14Initiated Aegis Capital Buy $15
Jan-09-17 08:43AM  SIGNAL GENETICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:30AM  Signal Genetics Sets Date for Special Meeting of Stockholders GlobeNewswire
Dec-01-16 04:09PM  SIGNAL GENETICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibi +6.13%
Nov-29-16 05:10PM  SIGNAL GENETICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Nov-28-16 09:03AM  SIGNAL GENETICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:30AM  Signal Genetics Regains Compliance with NASDAQ Minimum Bid Price Listing Requirement GlobeNewswire
Nov-07-16 07:04AM  Splits Calendar: Signal Genetics splits before market open today (1:15 ratio) -11.59%
Nov-03-16 08:53AM  SIGNAL GENETICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits -16.67%
Nov-02-16 06:12AM  SIGNAL GENETICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits -27.27%
Nov-01-16 01:04PM  SIGNAL GENETICS, INC. Financials +37.88%
06:33AM  SIGNAL GENETICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to Rights
Oct-31-16 08:02PM  miRagen Therapeutics and Signal Genetics Sign Merger Agreement Business Wire +7.81%
Oct-28-16 12:16PM  Signal Genetics, Inc. :SGNL-US: Earnings Analysis: Q3, 2016 By the Numbers : October 28, 2016 -22.38%
Oct-26-16 04:08PM  SIGNAL GENETICS, INC. Files SEC form 10-Q, Quarterly Report
Aug-18-16 10:27AM  Signal Genetics, Inc. :SGNL-US: Earnings Analysis: Q2, 2016 By the Numbers : August 18, 2016
Aug-15-16 04:10PM  SIGNAL GENETICS, INC. Files SEC form 10-Q, Quarterly Report
Jun-23-16 04:06PM  SIGNAL GENETICS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial +5.29%
Jun-16-16 05:28PM  SIGNAL GENETICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-26-16 05:13PM  SIGNAL GENETICS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Stand
08:30AM  Signal Genetics Receives Extension to Comply with Nasdaq Continued Listing Requirement GlobeNewswire
May-25-16 08:30AM  Signal Genetics to Present at the LD Micro Invitational Accesswire
May-23-16 12:14PM  Signal Genetics, Inc. :SGNL-US: Earnings Analysis: Q1, 2016 By the Numbers : May 23, 2016
May-16-16 08:36AM  SIGNAL GENETICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Fi
08:30AM  Signal Genetics Highlights Recent Achievements and Reports First Quarter 2016 Financial Results GlobeNewswire
Mar-21-16 04:41PM  SIGNAL GENETICS, INC. Files SEC form 10-K, Annual Report
11:57AM  Signal Genetics, Inc. :SGNL-US: Earnings Analysis: 2015 By the Numbers
Mar-16-16 04:07PM  SIGNAL GENETICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Fi
04:05PM  Signal Genetics Highlights Recent Achievements and Reports Fourth Quarter and Full-Year 2015 Financial Results GlobeNewswire
07:07AM  Q4 2015 Signal Genetics Inc Earnings Release - After Market Close
Mar-10-16 08:30AM  Signal Genetics to Host 2015 Annual Corporate Update Call GlobeNewswire
Jan-12-16 11:50AM  Signal Genetics, Inc. (NASDAQ: SGNL) Begins Patient Study for its MyPRS(R) Assay Accesswire -5.41%
Jan-08-16 07:11AM  Coverage initiated on Signal Genetics by Rodman & Renshaw
Jan-06-16 08:30AM  Signal Genetics and MD Anderson Cancer Center Enter Into Sponsored Research Agreement GlobeNewswire
Dec-29-15 02:59PM  Why Aegis Capital Loves Signal Genetics +5.63%
Nov-30-15 05:26PM  SIGNAL GENETICS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Stand
Nov-24-15 08:30AM  Signal Genetics to Present at the 8th Annual LD Micro Main Event GlobeNewswire
Nov-13-15 04:02PM  SIGNAL GENETICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Fi -6.25%
Nov-12-15 04:06PM  Signal Genetics Highlights Recent Achievements and Reports Third Quarter 2015 Financial Results GlobeNewswire
Nov-05-15 08:30AM  Signal Genetics' MyPRS(R) Highlighted in the Journal Leukemia GlobeNewswire
Oct-20-15 08:30AM  Signal Genetics Expands Reimbursement of MyPRS(R) With Additional Preferred Provider Organization Agreements GlobeNewswire
Oct-02-15 08:30AM  Updated Presentation Time: Signal Genetics to Present at the 2015 Aegis Growth Conference GlobeNewswire +10.12%
Oct-01-15 08:30AM  Signal Genetics to Present at the 2015 Aegis Growth Conference GlobeNewswire -7.13%
Sep-24-15 08:36AM  SIGNAL GENETICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
08:30AM  Signal Genetics Granted First European Patent for MyPRS(R) GlobeNewswire
Sep-23-15 12:38PM  Three Stocks Register Large Gains Today but Hedge Fund Data Suggest You Should Ignore the Hype at Insider Monkey
10:45AM  What Signal Genetics Gets With New Master Service Agreement
10:43AM  Signal Genetics (SGNL) Stock Jumps on New Master Service Agreement at TheStreet
07:06AM  SIGNAL GENETICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Finan
07:00AM  Signal Genetics Announces Master Service Agreement With Major Biopharmaceutical Partner GlobeNewswire
Sep-17-15 07:06AM  SIGNAL GENETICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
07:00AM  Signal Genetics Appoints Richard Bender, MD, FACP as Chief Medical Officer GlobeNewswire
Sep-08-15 08:37AM  SIGNAL GENETICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Other
08:30AM  Signal Genetics and Moffitt Cancer Center Enter Into Sponsored Research Agreement in Multiple Myeloma GlobeNewswire
Sep-02-15 08:30AM  Signal Genetics to Present at the Rodman & Renshaw 17th Annual Global Investment Conference GlobeNewswire
Aug-14-15 06:41PM  SIGNAL GENETICS, INC. Files SEC form 10-Q, Quarterly Report -9.37%
Aug-12-15 04:38PM  SIGNAL GENETICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Fi
04:31PM  Signal Genetics Highlights Recent Achievements and Reports Second Quarter 2015 Financial Results GlobeNewswire
Aug-05-15 08:30AM  Signal Genetics Expands Reimbursement of MyPRS(R) with America's Choice Provider Network Agreement GlobeNewswire
Jul-31-15 08:54AM  5 Stocks Ready for Breakouts at TheStreet
Jun-30-15 02:16PM  Morning Market Gainers: Signal Genetics Inc (SGNL), Asterias Biotherapeutics Inc (AST), TreeHouse Foods Inc. (THS) at Insider Monkey +47.97%
09:58AM  Signal Genetics (SGNL) Stock Gains on New Master Service Agreement at TheStreet
08:30AM  Signal Genetics Announces Master Service Agreement GlobeNewswire
Jun-23-15 04:49PM  SIGNAL GENETICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote
08:06AM  Time To Buy Signal Genetics? Chardan Thinks So
May-27-15 08:30AM  Signal Genetics to Present at the LD Micro Invitational Conference GlobeNewswire +10.34%
May-15-15 04:40PM  SIGNAL GENETICS, INC. Files SEC form 10-Q, Quarterly Report
May-14-15 04:25PM  SIGNAL GENETICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Fi
04:15PM  Signal Genetics Highlights Recent Achievements and Reports First Quarter 2015 Financial Results GlobeNewswire
Apr-30-15 08:56AM  Signal Genetics' Laboratory Receives Accreditation From College of American Pathologists at noodls
08:30AM  Signal Genetics' Laboratory Receives Accreditation From College of American Pathologists GlobeNewswire
Mar-30-15 08:54AM  Signal Genetics Highlights Recent Achievements and Reports Full-Year 2014 Financial Results at noodls
08:30AM  Signal Genetics Highlights Recent Achievements and Reports Full-Year 2014 Financial Results GlobeNewswire
Mar-27-15 09:16AM  SIGNAL GENETICS, INC. Files SEC form 10-K, Annual Report
Mar-17-15 04:36PM  Signal Genetics Announces Exercise of Over-Allotment Option at noodls
Mar-02-15 08:30AM  Signal Genetics Announces Exercise of Over-Allotment Option GlobeNewswire
Feb-23-15 08:54AM  Signal Genetics Announces Closing of $9,000,000 Public Offering at noodls +6.23%
08:30AM  Signal Genetics Announces Closing of $9,000,000 Public Offering GlobeNewswire
Feb-17-15 12:16PM  Signal Genetics (SGNL) Stock Plunges Today After Pricing Public Offering at TheStreet -32.99%
11:08AM  Signal Genetics Prices $9,000,000 Public Offering at noodls
11:02AM  Signal Genetics Prices $9,000,000 Public Offering GlobeNewswire
Feb-02-15 08:40AM  Signal Genetics Receives Conditional Approval of Investigational Device Exemption for MyPRS(R) at noodls
08:30AM  Signal Genetics Receives Conditional Approval of Investigational Device Exemption for MyPRS(R) GlobeNewswire
Jan-06-15 08:30AM  Signal Genetics Appoints Sudipto Sur Chief Information Officer GlobeNewswire
Nov-14-14 08:31AM  SIGNAL GENETICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Fi EDGAR Online
08:30AM  Signal Genetics Provides Overview of Recent Corporate Achievements GlobeNewswire
Sep-25-14 08:30AM  Signal Genetics Extends Exclusive Laboratory Services Agreements With the University of Arkansas for Medical Sciences GlobeNewswire
Sep-24-14 04:05PM  SIGNAL GENETICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
Sep-08-14 08:30AM  Signal Genetics to Present at the Aegis Capital Corp. 2014 Healthcare & Technology Conference GlobeNewswire
Aug-20-14 04:31PM  SIGNAL GENETICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial EDGAR Online
Aug-14-14 05:20PM  SIGNAL GENETICS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
Aug-11-14 08:30AM  Signal Genetics Appoints Michael C. Cerio Senior Vice President of Commercial Strategy and Business Development GlobeNewswire
Jul-23-14 04:11PM  SIGNAL GENETICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financ EDGAR Online
Jul-22-14 08:30AM  Signal Genetics Appoints Tamara A. Seymour New Chief Financial Officer GlobeNewswire
Jun-30-14 08:30AM  Signal Genetics Obtains New York State Approval for MyPRS(R) Multiple Myeloma Prognostic Test GlobeNewswire
Jun-23-14 02:17PM  Signal Genetics, Inc. Announces Closing of Initial Public Offering of 850,000 Shares of Common Stock GlobeNewswire
Jun-17-14 06:32PM  Signal Genetics, Inc. Announces Pricing of Its Initial Public Offering of Common Stock GlobeNewswire
Signal Genetics, Inc., a commercial stage molecular genetic diagnostic company, focuses on providing diagnostic services that assist physicians in decision making for the care of patients suffering from cancer. The company primarily offers Myeloma Prognostic Risk Signature (MyPRS) test, a microarray-based gene expression profiling assay that tests for the presence of specific groups of genes that could predict low or high level risk of early relapse in patients suffering from multiple myeloma. Signal Genetics, Inc. was founded in 2010 and is headquartered in Carlsbad, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Riccitelli Samuel DPresident & CEOOct 31Option Exercise0.00200,0000674,530Nov 02 08:37 PM
Riccitelli Samuel DPresident & CEOJun 28Option Exercise0.00124,2510539,365Jun 30 04:56 PM
Riccitelli Samuel DPresident & CEOFeb 11Option Exercise0.00124,2520469,382Feb 12 05:13 PM